LANZEP

This brand name is authorized in Nigeria.

Active ingredients

The drug LANZEP contains one active pharmaceutical ingredient (API):

1	Olanzapine UNII N7U69T4SZR - OLANZAPINE
	Olanzapine is an antipsychotic, antimanic and mood stabilising agent that demonstrates a broad pharmacologic profile across a number of receptor systems.
	Read more about Olanzapine

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
04-9701	Tablet	Lanzep-5 Tablet TAB 5 mg 3 x 10's (in Alu-Alu blisters)	Film coated Tablets Yellow coloured round shaped biconvex film coated tablet with embossed "LS" on one side and plain on other side	25/09/2024
04-9764	Tablet	Lanzep-10 Tablet TAB 10 mg 3 x 10's (in Alu-Alu blisters)	Film-coated Tablet. Orange-coloured round-shaped bi-convex film-coated tablet with embossed "L 10" and plain on other side	28/08/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N05AH03	Olanzapine	N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AH Diazepines, oxazepines and thiazepines
Discover more medicines within N05AH03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	04-9701, 04-9764